Research and findings from the European Alliance of Associations for Rheumatology 2026 Congress are providing new insights into gout management. Studies and analyses presented at the congress are exploring various aspects of gout treatment, including the benefits of continuing therapy during remission and the potential of new therapeutics. The congress is also discussing recent developments and future opportunities in gout management, although it is unclear what specific recommendations or findings have been reached.